Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genomic Cancer Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Fluorescence In Situ Hybridization
1.2.3 Polymerase Chain Reaction
1.2.4 Microarray Technology
1.2.5 Serum Proteomics
1.2.6 Nucleic Acid Sequencing
1.3 Market by Application
1.3.1 Global Genomic Cancer Testing Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Speciality Clinics
1.3.4 Research Institutes
1.3.5 Diagnostics Laboratories
1.3.6 Biopharmaceutical Companies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genomic Cancer Testing Market Perspective (2018-2033)
2.2 Genomic Cancer Testing Growth Trends by Region
2.2.1 Global Genomic Cancer Testing Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Genomic Cancer Testing Historic Market Size by Region (2018-2023)
2.2.3 Genomic Cancer Testing Forecasted Market Size by Region (2024-2033)
2.3 Genomic Cancer Testing Market Dynamics
2.3.1 Genomic Cancer Testing Industry Trends
2.3.2 Genomic Cancer Testing Market Drivers
2.3.3 Genomic Cancer Testing Market Challenges
2.3.4 Genomic Cancer Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genomic Cancer Testing Players by Revenue
3.1.1 Global Top Genomic Cancer Testing Players by Revenue (2018-2023)
3.1.2 Global Genomic Cancer Testing Revenue Market Share by Players (2018-2023)
3.2 Global Genomic Cancer Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genomic Cancer Testing Revenue
3.4 Global Genomic Cancer Testing Market Concentration Ratio
3.4.1 Global Genomic Cancer Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genomic Cancer Testing Revenue in 2022
3.5 Genomic Cancer Testing Key Players Head office and Area Served
3.6 Key Players Genomic Cancer Testing Product Solution and Service
3.7 Date of Enter into Genomic Cancer Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Genomic Cancer Testing Breakdown Data by Type
4.1 Global Genomic Cancer Testing Historic Market Size by Type (2018-2023)
4.2 Global Genomic Cancer Testing Forecasted Market Size by Type (2024-2033)
5 Genomic Cancer Testing Breakdown Data by Application
5.1 Global Genomic Cancer Testing Historic Market Size by Application (2018-2023)
5.2 Global Genomic Cancer Testing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Genomic Cancer Testing Market Size (2018-2033)
6.2 North America Genomic Cancer Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Genomic Cancer Testing Market Size by Country (2018-2023)
6.4 North America Genomic Cancer Testing Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genomic Cancer Testing Market Size (2018-2033)
7.2 Europe Genomic Cancer Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Genomic Cancer Testing Market Size by Country (2018-2023)
7.4 Europe Genomic Cancer Testing Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genomic Cancer Testing Market Size (2018-2033)
8.2 Asia-Pacific Genomic Cancer Testing Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Genomic Cancer Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Genomic Cancer Testing Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Genomic Cancer Testing Market Size (2018-2033)
9.2 Latin America Genomic Cancer Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Genomic Cancer Testing Market Size by Country (2018-2023)
9.4 Latin America Genomic Cancer Testing Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genomic Cancer Testing Market Size (2018-2033)
10.2 Middle East & Africa Genomic Cancer Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Genomic Cancer Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Genomic Cancer Testing Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Devyser
11.1.1 Devyser Company Detail
11.1.2 Devyser Business Overview
11.1.3 Devyser Genomic Cancer Testing Introduction
11.1.4 Devyser Revenue in Genomic Cancer Testing Business (2018-2023)
11.1.5 Devyser Recent Development
11.2 Agendia
11.2.1 Agendia Company Detail
11.2.2 Agendia Business Overview
11.2.3 Agendia Genomic Cancer Testing Introduction
11.2.4 Agendia Revenue in Genomic Cancer Testing Business (2018-2023)
11.2.5 Agendia Recent Development
11.3 Illumina
11.3.1 Illumina Company Detail
11.3.2 Illumina Business Overview
11.3.3 Illumina Genomic Cancer Testing Introduction
11.3.4 Illumina Revenue in Genomic Cancer Testing Business (2018-2023)
11.3.5 Illumina Recent Development
11.4 Personal Genome Diagnostics
11.4.1 Personal Genome Diagnostics Company Detail
11.4.2 Personal Genome Diagnostics Business Overview
11.4.3 Personal Genome Diagnostics Genomic Cancer Testing Introduction
11.4.4 Personal Genome Diagnostics Revenue in Genomic Cancer Testing Business (2018-2023)
11.4.5 Personal Genome Diagnostics Recent Development
11.5 Veracyte
11.5.1 Veracyte Company Detail
11.5.2 Veracyte Business Overview
11.5.3 Veracyte Genomic Cancer Testing Introduction
11.5.4 Veracyte Revenue in Genomic Cancer Testing Business (2018-2023)
11.5.5 Veracyte Recent Development
11.6 Pacific Biosciences of California
11.6.1 Pacific Biosciences of California Company Detail
11.6.2 Pacific Biosciences of California Business Overview
11.6.3 Pacific Biosciences of California Genomic Cancer Testing Introduction
11.6.4 Pacific Biosciences of California Revenue in Genomic Cancer Testing Business (2018-2023)
11.6.5 Pacific Biosciences of California Recent Development
11.7 Qiagen
11.7.1 Qiagen Company Detail
11.7.2 Qiagen Business Overview
11.7.3 Qiagen Genomic Cancer Testing Introduction
11.7.4 Qiagen Revenue in Genomic Cancer Testing Business (2018-2023)
11.7.5 Qiagen Recent Development
11.8 Agilent Technologies
11.8.1 Agilent Technologies Company Detail
11.8.2 Agilent Technologies Business Overview
11.8.3 Agilent Technologies Genomic Cancer Testing Introduction
11.8.4 Agilent Technologies Revenue in Genomic Cancer Testing Business (2018-2023)
11.8.5 Agilent Technologies Recent Development
11.9 Natera
11.9.1 Natera Company Detail
11.9.2 Natera Business Overview
11.9.3 Natera Genomic Cancer Testing Introduction
11.9.4 Natera Revenue in Genomic Cancer Testing Business (2018-2023)
11.9.5 Natera Recent Development
11.10 Bio Rad Laboratories
11.10.1 Bio Rad Laboratories Company Detail
11.10.2 Bio Rad Laboratories Business Overview
11.10.3 Bio Rad Laboratories Genomic Cancer Testing Introduction
11.10.4 Bio Rad Laboratories Revenue in Genomic Cancer Testing Business (2018-2023)
11.10.5 Bio Rad Laboratories Recent Development
11.11 Myriad Genetics
11.11.1 Myriad Genetics Company Detail
11.11.2 Myriad Genetics Business Overview
11.11.3 Myriad Genetics Genomic Cancer Testing Introduction
11.11.4 Myriad Genetics Revenue in Genomic Cancer Testing Business (2018-2023)
11.11.5 Myriad Genetics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Genomic Cancer Testing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Fluorescence In Situ Hybridization
Table 3. Key Players of Polymerase Chain Reaction
Table 4. Key Players of Microarray Technology
Table 5. Key Players of Serum Proteomics
Table 6. Key Players of Nucleic Acid Sequencing
Table 7. Global Genomic Cancer Testing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Genomic Cancer Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Genomic Cancer Testing Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Genomic Cancer Testing Market Share by Region (2018-2023)
Table 11. Global Genomic Cancer Testing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Genomic Cancer Testing Market Share by Region (2024-2033)
Table 13. Genomic Cancer Testing Market Trends
Table 14. Genomic Cancer Testing Market Drivers
Table 15. Genomic Cancer Testing Market Challenges
Table 16. Genomic Cancer Testing Market Restraints
Table 17. Global Genomic Cancer Testing Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Genomic Cancer Testing Market Share by Players (2018-2023)
Table 19. Global Top Genomic Cancer Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomic Cancer Testing as of 2022)
Table 20. Ranking of Global Top Genomic Cancer Testing Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Genomic Cancer Testing Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Genomic Cancer Testing Product Solution and Service
Table 24. Date of Enter into Genomic Cancer Testing Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Genomic Cancer Testing Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Genomic Cancer Testing Revenue Market Share by Type (2018-2023)
Table 28. Global Genomic Cancer Testing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Genomic Cancer Testing Revenue Market Share by Type (2024-2033)
Table 30. Global Genomic Cancer Testing Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Genomic Cancer Testing Revenue Market Share by Application (2018-2023)
Table 32. Global Genomic Cancer Testing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Genomic Cancer Testing Revenue Market Share by Application (2024-2033)
Table 34. North America Genomic Cancer Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America Genomic Cancer Testing Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Genomic Cancer Testing Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe Genomic Cancer Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe Genomic Cancer Testing Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Genomic Cancer Testing Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific Genomic Cancer Testing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific Genomic Cancer Testing Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Genomic Cancer Testing Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America Genomic Cancer Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America Genomic Cancer Testing Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Genomic Cancer Testing Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa Genomic Cancer Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa Genomic Cancer Testing Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Genomic Cancer Testing Market Size by Country (2024-2033) & (US$ Million)
Table 49. Devyser Company Detail
Table 50. Devyser Business Overview
Table 51. Devyser Genomic Cancer Testing Product
Table 52. Devyser Revenue in Genomic Cancer Testing Business (2018-2023) & (US$ Million)
Table 53. Devyser Recent Development
Table 54. Agendia Company Detail
Table 55. Agendia Business Overview
Table 56. Agendia Genomic Cancer Testing Product
Table 57. Agendia Revenue in Genomic Cancer Testing Business (2018-2023) & (US$ Million)
Table 58. Agendia Recent Development
Table 59. Illumina Company Detail
Table 60. Illumina Business Overview
Table 61. Illumina Genomic Cancer Testing Product
Table 62. Illumina Revenue in Genomic Cancer Testing Business (2018-2023) & (US$ Million)
Table 63. Illumina Recent Development
Table 64. Personal Genome Diagnostics Company Detail
Table 65. Personal Genome Diagnostics Business Overview
Table 66. Personal Genome Diagnostics Genomic Cancer Testing Product
Table 67. Personal Genome Diagnostics Revenue in Genomic Cancer Testing Business (2018-2023) & (US$ Million)
Table 68. Personal Genome Diagnostics Recent Development
Table 69. Veracyte Company Detail
Table 70. Veracyte Business Overview
Table 71. Veracyte Genomic Cancer Testing Product
Table 72. Veracyte Revenue in Genomic Cancer Testing Business (2018-2023) & (US$ Million)
Table 73. Veracyte Recent Development
Table 74. Pacific Biosciences of California Company Detail
Table 75. Pacific Biosciences of California Business Overview
Table 76. Pacific Biosciences of California Genomic Cancer Testing Product
Table 77. Pacific Biosciences of California Revenue in Genomic Cancer Testing Business (2018-2023) & (US$ Million)
Table 78. Pacific Biosciences of California Recent Development
Table 79. Qiagen Company Detail
Table 80. Qiagen Business Overview
Table 81. Qiagen Genomic Cancer Testing Product
Table 82. Qiagen Revenue in Genomic Cancer Testing Business (2018-2023) & (US$ Million)
Table 83. Qiagen Recent Development
Table 84. Agilent Technologies Company Detail
Table 85. Agilent Technologies Business Overview
Table 86. Agilent Technologies Genomic Cancer Testing Product
Table 87. Agilent Technologies Revenue in Genomic Cancer Testing Business (2018-2023) & (US$ Million)
Table 88. Agilent Technologies Recent Development
Table 89. Natera Company Detail
Table 90. Natera Business Overview
Table 91. Natera Genomic Cancer Testing Product
Table 92. Natera Revenue in Genomic Cancer Testing Business (2018-2023) & (US$ Million)
Table 93. Natera Recent Development
Table 94. Bio Rad Laboratories Company Detail
Table 95. Bio Rad Laboratories Business Overview
Table 96. Bio Rad Laboratories Genomic Cancer Testing Product
Table 97. Bio Rad Laboratories Revenue in Genomic Cancer Testing Business (2018-2023) & (US$ Million)
Table 98. Bio Rad Laboratories Recent Development
Table 99. Myriad Genetics Company Detail
Table 100. Myriad Genetics Business Overview
Table 101. Myriad Genetics Genomic Cancer Testing Product
Table 102. Myriad Genetics Revenue in Genomic Cancer Testing Business (2018-2023) & (US$ Million)
Table 103. Myriad Genetics Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Genomic Cancer Testing Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Genomic Cancer Testing Market Share by Type: 2022 VS 2033
Figure 3. Fluorescence In Situ Hybridization Features
Figure 4. Polymerase Chain Reaction Features
Figure 5. Microarray Technology Features
Figure 6. Serum Proteomics Features
Figure 7. Nucleic Acid Sequencing Features
Figure 8. Global Genomic Cancer Testing Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global Genomic Cancer Testing Market Share by Application: 2022 VS 2033
Figure 10. Hospitals Case Studies
Figure 11. Speciality Clinics Case Studies
Figure 12. Research Institutes Case Studies
Figure 13. Diagnostics Laboratories Case Studies
Figure 14. Biopharmaceutical Companies Case Studies
Figure 15. Genomic Cancer Testing Report Years Considered
Figure 16. Global Genomic Cancer Testing Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 17. Global Genomic Cancer Testing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 18. Global Genomic Cancer Testing Market Share by Region: 2022 VS 2033
Figure 19. Global Genomic Cancer Testing Market Share by Players in 2022
Figure 20. Global Top Genomic Cancer Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomic Cancer Testing as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Genomic Cancer Testing Revenue in 2022
Figure 22. North America Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. North America Genomic Cancer Testing Market Share by Country (2018-2033)
Figure 24. United States Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Genomic Cancer Testing Market Share by Country (2018-2033)
Figure 28. Germany Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Asia-Pacific Genomic Cancer Testing Market Share by Region (2018-2033)
Figure 36. China Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Japan Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. South Korea Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Southeast Asia Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. India Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Australia Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Latin America Genomic Cancer Testing Market Share by Country (2018-2033)
Figure 44. Mexico Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Brazil Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East & Africa Genomic Cancer Testing Market Share by Country (2018-2033)
Figure 48. Turkey Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Saudi Arabia Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Devyser Revenue Growth Rate in Genomic Cancer Testing Business (2018-2023)
Figure 51. Agendia Revenue Growth Rate in Genomic Cancer Testing Business (2018-2023)
Figure 52. Illumina Revenue Growth Rate in Genomic Cancer Testing Business (2018-2023)
Figure 53. Personal Genome Diagnostics Revenue Growth Rate in Genomic Cancer Testing Business (2018-2023)
Figure 54. Veracyte Revenue Growth Rate in Genomic Cancer Testing Business (2018-2023)
Figure 55. Pacific Biosciences of California Revenue Growth Rate in Genomic Cancer Testing Business (2018-2023)
Figure 56. Qiagen Revenue Growth Rate in Genomic Cancer Testing Business (2018-2023)
Figure 57. Agilent Technologies Revenue Growth Rate in Genomic Cancer Testing Business (2018-2023)
Figure 58. Natera Revenue Growth Rate in Genomic Cancer Testing Business (2018-2023)
Figure 59. Bio Rad Laboratories Revenue Growth Rate in Genomic Cancer Testing Business (2018-2023)
Figure 60. Myriad Genetics Revenue Growth Rate in Genomic Cancer Testing Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed